← All stories
Markets
Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript
Covered by 1 outlet
All coverage · 2 articles
Seeking Alpha
·Aug 6, 12:44 UTC
Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study - Slideshow
Seeking Alpha
·Aug 6, 12:44 UTC